CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Impact and predictors of reducing prescribed doses of fludarabine, cyclophosphamide and rituximab (FCR) in frontline treatment of chronic lymphocytic leukemia (CLL)
Author
Bahlo J.
Cramer P.
+14 more
Eichhorst B.
Fink A. M.
Fischer K.
Goede V.
Gross-Opphoff-Mueller C.
Hallek M.
Kluth S.
Kovacs G.
Kreuzer K. -A.
Langerbeins P.
Maurer C.
Stilgenbauer S.
von Tresckow J.
Wendtner C. -M.
Publication venue
'S. Karger AG'
Publication date
01/01/2015
Field of study
No full text
Kölner UniversitätsPublikationsServer